IndraLab

Statements

USP22 deubiquitinates PTGS2. 1 / 1

1 |

"In non-small cell lung cancer (NSCLC), aberrant expression of USP22 is a predictor of poor survival, as is high expression of cyclooxygenase-2 (COX-2)."

25817787

INDRA sources:

Colored badges next to statement headings correspond to evidence counts from knowledge sources, as shown below. Badges to the left of the | separator correspond to curated knowledge base sources, and badges to the right of it correspond to machine reading systems.

IndraLab

Statements

USP22 deubiquitinates PTGS2. 1 / 1

INDRA sources:

Databases

Reading